Fagron Completes Acquisition of Purifarma
January 6, 2026
Fagron has announced the completion of its acquisition of Purifarma in Brazil, following CADE approval in October 2025. The company said the deal strengthens its scalable platform in essentials, with opportunities to improve the product mix, expand to industrial customers, and leverage purchasing advantages across Latin America.
- Buyers
- Fagron
- Targets
- Purifarma
- Industry
- Healthcare Services
- Location
- Brazil
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Fagron Completes Acquisition of University Compounding Pharmacy (UCP)
January 12, 2026
Healthcare Services
Fagron has completed its acquisition of University Compounding Pharmacy (UCP), a California-based 503A pharmaceutical compounder focused on the health and wellness segment. The deal, initially announced in September 2025, closed following customary clearance and reinforces Fagron’s strategy to build a nationwide U.S. compounding platform spanning both 503A and 503B services.
-
Fagron Completes Acquisition of University Compounding Pharmacy (UCP) in North America
January 12, 2026
Healthcare Services
Fagron has completed its acquisition of University Compounding Pharmacy (UCP), a 503A compounding pharmacy based in California and focused on health and wellness. The deal, announced in September 2025, strengthens Fagron’s U.S. footprint—particularly in California—and supports its strategy to build a nationwide platform spanning both 503A and 503B services.
-
Fagron Completes Acquisition of Purifarma in Brazil
January 6, 2026
Healthcare Services
Fagron announced the completion of its acquisition of Purifarma in Brazil following CADE competition clearance in October 2025. The deal strengthens Fagron’s scalable pharmaceutical compounding platform and supports its disciplined buy-and-build strategy, with an enterprise value of approximately R$250 million.
-
PerkinElmer Acquires Project Farma
March 11, 2025
Healthcare Services
PerkinElmer announced the acquisition of Project Farma, a life sciences consultancy focused on advancing technical operations from ideation through commercialization. The deal expands PerkinElmer’s OneSource professional services offering for the life sciences value chain.
-
Adragos Pharma Acquires Baccinex
February 6, 2025
Pharmaceuticals
Adragos Pharma, a Munich-headquartered CDMO, has acquired Baccinex, a Swiss sterile fill-finish specialist based in Courroux, Jura. The acquisition adds a US FDA- and EU-GMP-certified 6,200 m² facility and over 110 sterile fill-finish experts to Adragos' global manufacturing network, enhancing its clinical and commercial sterile manufacturing capabilities.
-
BRANDED Group Acquires Puracy
October 6, 2021
Consumer Products
BRANDED Group has completed the full acquisition of Puracy, a plant-based household cleaning and personal care brand founded in 2013. The deal pairs Puracy's natural-product portfolio and founder team with BRANDED's e-commerce infrastructure and resources to accelerate brand growth and global expansion.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.